Timing of Acute Myocardial Infarction in Patients Undergoing Total Hip or Knee Replacement A Nationwide Cohort Study

被引:64
|
作者
Lalmohamed, Arief [1 ]
Vestergaard, Peter [2 ]
Klop, Corinne [1 ]
Grove, Erik Lerkevang [3 ]
de Boer, Anthonius [1 ]
Leufkens, Hubertus G. M. [1 ]
van Staa, Tjeerd P. [1 ,4 ]
de Vries, Frank [1 ,4 ,5 ]
机构
[1] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[2] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark
[4] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England
[5] Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, Maastricht, Netherlands
关键词
RISK-FACTORS; MORTALITY; EPIDEMIOLOGY; ARTHROPLASTY; COMPLICATIONS; NSAIDS;
D O I
10.1001/archinternmed.2012.2713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Limited evidence suggests that the risk of acute myocardial infarction (AMI) may be increased shortly after total hip replacement (THR) and total knee replacement (TKR) surgery. However, risk of AMI in these patients has not been compared against matched controls who have not undergone surgery. The objective of this study was to evaluate the timing of AMI in patients undergoing THR or TKR surgery compared with matched controls. Methods: Retrospective, nationwide cohort study within the Danish national registries. All patients who underwent a primary THR or TKR (n=95 227) surgery from January 1, 1998, through December 31, 2007, were selected and matched to 3 controls (no THR or TKR) by age, sex, and geographic region. All study participants were followed up for AMI, and disease- and medication history adjusted hazard ratios (HRs) were calculated. Results: During the first 2 postoperative weeks, the risk of AMI was substantially increased in THR patients compared with controls (adjusted HR, 25.5; 95% CI, 17.1-37.9). The risk remained elevated for 2 to 6 weeks after surgery (adjusted HR, 5.05; 95% CI, 3.58-7.13) and then decreased to baseline levels. For TKR patients, AMI risk was also increased during the first 2 weeks (adjusted HR, 30.9; 95% CI, 11.1-85.5) but did not differ from controls after the first 2 weeks. The absolute 6-week risk of AMI was 0.51% in THR patients and 0.21% in TKR patients. Conclusions: Risk of AMI is substantially increased in the first 2 weeks after THR (25-fold) and TKR (31-fold) surgery compared with controls. Risk assessment of AMI should be considered during the first 6 weeks after THR surgery and during the first 2 weeks after TKR surgery.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 50 条
  • [31] Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study
    Boden, R.
    Molin, E.
    Jernberg, T.
    Kieler, H.
    Lindahl, B.
    Sundstrom, J.
    JOURNAL OF INTERNAL MEDICINE, 2015, 277 (06) : 727 - 736
  • [32] Clostridium difficile in patients undergoing primary hip and knee replacement
    Jenkins, P. J.
    Teoh, K.
    Simpson, P. M.
    Dave, J.
    Simpson, A. H. W. R.
    Breusch, S.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2010, 92B (07): : 994 - 998
  • [33] Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study
    Wang, Cheng
    Liu, Qiaohui
    Sun, Lei
    Dai, Guofeng
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (06) : 281 - 290
  • [34] Risk of Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis: A Nationwide Cohort Study
    Egeberg, Alexander
    Thyssen, Jacob P.
    Jensen, Peter
    Gislason, Gunnar H.
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (07) : 819 - 824
  • [35] Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study
    Olesen, Jonas Bjerring
    Hansen, Peter Riis
    Abildstrom, Steen Zabell
    Andersson, Charlotte
    Weeke, Peter
    Schmiegelow, Michelle
    Erdal, Jesper
    Torp-Pedersen, Christian
    Gislason, Gunnar Hilmar
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (02) : 146 - 153
  • [36] Optimal timing for elective total hip replacement in HIV-positive patients
    Chang, Chun-Hung
    Tsai, Shang-Wen
    Chen, Cheng-Fong
    Wu, Po-Kuei
    Wong, Wing-Wai
    Chang, Ming-Chau
    Chen, Wei-Ming
    ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2018, 104 (05) : 671 - 674
  • [37] Tranexamic acid in total knee replacement and total hip replacement - a single-center retrospective, observational study
    Konarski, Wojciech
    Pobozy, Tomasz
    Hordowicz, Martyna
    ORTHOPEDIC REVIEWS, 2022, 14 (02)
  • [38] Sitagliptin and cardiovascular outcomes in diabetic patients with chronic kidney disease and acute myocardial infarction: A nationwide cohort study
    Chen, Dong-Yi
    Wang, Szu-Heng
    Mao, Chun-Tai
    Tsai, Ming-Lung
    Lin, Yu-Sheng
    Chou, Chung-Chuan
    Wen, Ming-Shien
    Wang, Chun-Chieh
    Hsieh, I-Chang
    Hung, Kuo-Chun
    Chen, Tien-Hsing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 : 200 - 206
  • [39] Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
    Yi Yang
    Zhenjun Yao
    Wenda Dai
    Peng Shi
    Lei luo
    Chi Zhang
    Journal of Orthopaedic Surgery and Research, 9
  • [40] Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study
    Morten Malmborg
    Christine Benn Christiansen
    Michelle D. Schmiegelow
    Christian Torp-Pedersen
    Gunnar Gislason
    Morten Schou
    BMC Cardiovascular Disorders, 18